Health
Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities – News-Medical.Net
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications…
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
In a review article in Trends in Cancer, the team presented evidence that immunotherapies such as immune checkpoint inhibitors (which enable T cells to attack and kill cancer…
-
Business15 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Business19 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News19 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’